HBOT Conversations:
Dr. Hemal Mehta & Fasting (Part 1)
Dr. Hemal Mehta, MD is a Medical Director and an Independent Medical Examiner who focuses on pain management through a Regenerative medicine approach.
Dr. Mehta is Board Certified in Physical Medicine and Pain Management. He received his Doctor of Medicine Degree from Ross University School of Medicine and completed his residency at East Carolina. He is the Medical Director of Vibrant Health of North Carolina, Tennessee Integrative Pain Institute, and TN Integrative Healthcare: Musculoskeletal and Regenerative Center; additionally, Dr. Mehta is the attending physician at Nashville Regenerative Orthopedics.
Dr. Mehta is the 2013 recipient of the Inaugural Patient Appreciation Award at Nashville Academy of Medicine, and the 2004 Research Resident of the Year for East Carolina University.
Dr. Mehta has extensive experience with stem cell proliferation, and angiogenesis. He has incorporated Ozone Injection Therapy, PRP (Platelet-Rich Plasma) Injections, Hyperbaric Oxygen Therapy and Regenerative Matrix and Regenerative Medicine Procedures – to name a few – into his integrative wellness & longevity medical practices.
Watch the Podcast
HBOT News Network welcomes Dr. Hemal V. Mehta, M.D.; Medical Director of Vibrant Health of North Carolina.
After the first 10-15 years of his medical career focusing on interventional pain management, Dr. Mehta started to get involved in regenerative medicine. Regenerative medicines is a newer field of medicine involving PRP – Platelet Rich Plasma, stem cells, and different techniques (like HBOT) to help regenerate tissue in the body. When he first started using regenerative medicine, Dr. Mehta witnessed his patients doing considerably better and improving to the point that he was able to even wean them off of opioid pain medications. It was then that Dr. Mehta started integrating Hyperbaric Oxygen Therapy (HBOT or HBO Therapy) into some of the individualized patient healing plans he would develop for optimum healing.
Dr. Mehta touches on inflammation and how inflammation is one of the greatest problems people today deal with on a daily basis. Bad food choices, injuries and even stress all contributes to an increase of inflammation. Targeting inflammation is key to a healthy body and mind. Hyperbaric oxygen is an ideal therapy to address inflammation by upregulating the anti-inflammatory gene and downregulating the inflammatory gene. Dr. Mehta also mentions other therapies that assist in reducing inflammation in the joints and body — regenerative treatments using stem cells, PRP, ozone injections and exosomes.
According to Dr. Mehta, too much focus and energy goes into the promotion of pharmaceutical drugs to ease every ailment, indication or condition. He mentioned that when he was studying for his medical degree, he had almost two years of pharmacology classes but only one six-week semester of nutrition. It’s unfortunate that nutrition is not stressed more to young doctors, because much of the food we purchase at the grocery store is toxic and very pro-inflammatory. Dr. Mehta stresses that “you are what you eat”. Processed food is one of the worst things for our bodies. In his opinion, processed food is a major oxygen depleter since our bodies have to use extra energy and oxygen to break it down. Our bodies have to work much harder to break down processed junk, so he encourages our viewers to eat foods that are natural and avoid processed.
Since nutrition is a HUGE part of a person’s health, it’s important to look at alternatives to pharmaceutical drugs – like Hyperbaric Oxygen Therapy and fasting. In Dr. Mehta’s opinion, fasting is an excellent way for people to maintain health. Our bodies don’t necessarily NEED 3 meals a day, so when we overeat our bodies store the excess. Dr. Mehta is a big believer in fasting and reminds us that fasting is the ultimate detox. Food, especially processed food, sugar, and food with high fructose corn syrup, can be very pro-inflammatory and toxic. Fasting accelerates the process of the liver cleaning out toxins and gives our organs a much needed break to heal and rejuvenate. Fasting dates back to the Bible and beyond – every religious facet has fasting as part of their religion.
Fasting is nothing new, so try it and add Hyperbaric Oxygen Therapy into the mix too; something magical is truly happening to the body when you fast and receive HBOT. Dr. Mehta reminds us that there is also a strong association between fasting and reduced cancer risk, which he will get into more in Part 2 of our Conversations with Dr. Mehta about fasting & HBOT. Stay tuned to learn more about how fasting starves the cancer cells from the sugars and nutrients they need to feed and grow.
*Pease consult your doctor to see if fasting is right for you.
Guest

Dr. Hemal Mehta
Dr. Hemal Mehta specializes in non-opioid treatment for joint pain, osteoarthritis, spine pain and neuropathy. He is a board-certified Physical Medicine and Rehabilitation physician whose goal for patients is to reduce pain while increasing their level of function & quality of life. He received his Doctor of Medicine Degree from Ross University School of Medicine and completed his residency at East Carolina.
Dr. Mehta is the Medical Director of Vibrant Health of North Carolina, Tennessee Integrative Pain Institute, and TN Integrative Healthcare: Musculoskeletal and Regenerative Center; additionally, Dr. Mehta is the attending physician at Nashville Regenerative Orthopedics. He is the 2013 recipient of the Inaugural Patient Appreciation Award at Nashville Academy of Medicine, and the 2004 Research Resident of the Year for East Carolina University. He is a member of the American Academy of Physical Medicine & Rehabilitation, American Society of Interventional Pain Physicians, and American Association of Neuromuscular and Electrodiagnostic Medicine.
Subscribe Now, It’s Free!
Recent HBOT News
Clinical Trial – Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation
By doing this study, researchers hope to learn the following:
– The safety of hyperbaric oxygen administration in the setting of the autologous
transplant
– The effects of hyperbaric oxygen administration on neutrophil count recovery and
engraftment
Evaluation of hyperbaric oxygen therapy for chronic wounds.
Abstract: Treating chronic wounds is challenging. Despite standard wound care, some chronic wounds fail to heal. Therefore, hyperbaric oxygen therapy (HBOT) was developed as an adjunct to standard wound care. To evaluate the efficacy of HBOT for treating chronic...
Clinical Trial – Hyperbaric Oxygen Therapy for Mild Cognitive Impairment
Dementia is a very frequent cognitive disorder among elderly individuals. Its prevalence is
about 15-20% of the population over the age of 65. The most common forms of dementia among
the elderly demented patients are Alzheimer’s disease (AD) (prevalence of 70%) and Vascular
dementia (VD) (prevalence of about 30-40%).There is also a high rate (about 40%) of
coexisting of AD and VD among the dementia patients, defined as mixed dementia.
Mild Cognitive Impairment (MCI) is a pre-dementia phase of cognitive decline. It is also
considered as a prodromal phase of both VD and AD. Its basic clinical features include:
cognitive concern, reflecting a change in cognition, reported by the patient or informant
(i.e., historical or observed evidence of decline over time), with objective evidence of
impairment in one or more cognitive domains (i.e., by formal cognitive testing), as well as
preservation of independence in functional abilities and not being demented (i.e., no
significant impairment social or occupational functioning).
Hyperbaric oxygen therapy (HBOT) has been investigated for treatment of numerous diseases for
more than 300 years. The principal effect of HBOT is increasing the solubility of oxygen in
plasma to a level sufficient to support tissues with minimal oxygen supply carried on by
hemoglobin. Clinical studies published this year present convincing evidence that hyperbaric
oxygen therapy (HBOT) can be the coveted neurotherapeutic method for brain repair. Thus, it
seems that HBOT might be an efficient and clinically feasible method capable of increasing
tissue/cellular oxygenation and effectively evoking neuroplasticity in the chronically
vascular-lesioned areas during the post microvascular lesion phase.
This is a prospective, randomized, control crossed over, study evaluating the effect of HBOT
in patients suffering from Mild Cognitive Impairment and Vascular Subcortical Ischemia.
